Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (“Ecstasy”) and MDA (“Love”)
Authors:
- Aoife KeransAKAoife Kerans
- Barry O'NeillBOBarry O'Neill
- Andrew HarkinAHAndrew Harkin
- 1 January 2006
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 50 (1) , 69-80
Abstract
No abstract availableKeywords
Funding Information
- Health Research Board
- Irish Research Council for Science, Engineering and Technology
This publication has 33 references indexed in Scilit:
- The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)Pharmacological Reviews, 2003
- The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to ratsBritish Journal of Pharmacology, 2002
- Caveat Emptor Editors BewareNeuropsychopharmacology, 2001
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical StudiesNeuropsychobiology, 2000
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in AnimalsNeuropsychobiology, 2000
- Psychiatric complications of 'Ecstasy' useJournal of Psychopharmacology, 1994
- Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")The Lancet, 1992
- Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4‐methylenedioxymethamphetamine): Assessment using quantitative autoradiographySynapse, 1991
- Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the ratPharmacology Biochemistry and Behavior, 1989
- Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animalsToxicology and Applied Pharmacology, 1973